相关实验视频

Updated: Jul 17, 2026

Solubilization and Bio-conjugation of Quantum Dots and Bacterial Toxicity Assays by Growth Curve and Plate Count
13:06

Solubilization and Bio-conjugation of Quantum Dots and Bacterial Toxicity Assays by Growth Curve and Plate Count

Published on: July 11, 2012

14.3K

基于肝脏细胞毒性的基于基量子点的常见量子点替代品的比较

Seth Harris1, Kyoungtae Kim1

  • 1Department of Biology, Missouri State University, 901 S National, Springfield, MO 65897, USA.

Nanomaterials (Basel, Switzerland)
|July 13, 2024
PubMed
概括

添加碳点 (NCD) 在肝细胞中显示出量子点 (QD) 替代品中毒性最小. 其他替代品如InP/ZnS和CuInS2/ZnS也表现出一些毒性,与NCD不同.

关键词:
在CdSe/ZnSS中使用.在CuInS2/ZnS中使用.这是一种HepG2型肝炎.在P/ZnS中这是NCD的NCD.这就是THLE-2.光纳米颗粒是一种光纳米颗粒.肝脏细胞毒性 肝脏细胞毒性量子点是一个量子点.

更多相关视频

Compact Quantum Dots for Single-molecule Imaging17:14

Compact Quantum Dots for Single-molecule Imaging

Published on: October 9, 2012

18.1K
Synthesis of Cd-free InP/ZnS Quantum Dots Suitable for Biomedical Applications10:56

Synthesis of Cd-free InP/ZnS Quantum Dots Suitable for Biomedical Applications

Published on: February 6, 2016

13.6K

相关概念视频

¹H NMR Chemical Shift Equivalence: Homotopic and Heterotopic Protons01:03

¹H NMR Chemical Shift Equivalence: Homotopic and Heterotopic Protons

Protons in identical electronic environments within a molecule are chemically equivalent and have the same chemical shift. The replacement test is a useful tool to identify chemical equivalence and predict NMR spectra. A substituent replaces each of the protons being examined and the resulting molecules are compared. If the same molecule is obtained, the protons are equivalent or homotopic. Replacement of any hydrogens in ethane by chlorine yields chloroethane because all six protons are...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...